Yurou Zheng is a former equity analyst for Morningstar.* She covered stocks in the healthcare sector for the Asia team. Her coverage included biotech or biopharmaceuticals, medical-device companies, and service providers.
Before joining the equity research team in 2022, Zheng was in the Morningstar's fund data team for a regulation-driven project in the Australian market. Before Morningstar, she worked in a startup venture capital fund covering the healthcare sector and worked at PwC Deals in Italy.
Zheng holds a bachelor’s degree in international economics and finance from Bocconi University. She also passed the examination for the Fund Practitioner Qualification by the Asset Management Association of China (AMAC) in 2021.
*Morningstar Investment Adviser Singapore Pte. Ltd. (“Morningstar”) is a wholly owned subsidiary of Morningstar, Inc.
United States